Phase Space AI

Zscaler

ZS · investment memo

Valuation margin
demonstrated − required CAGR
-18.7%
Required CAGR
35.2%
Demonstrated
34.8%
Terminal margin
15.0%
Exit multiple
18.0x
Company state
C

Risk & exit

Four distinct questions, one field each. A price is not a thesis: the trigger below forces a re-underwrite and freezes further purchases — it is never an automatic sell.

Risk trigger
16% below the memo price
$129.29
Forward E[R]
vs a 0% floor
+18.4%

A daily close below $129.29 triggers a mandatory re-underwrite and freezes further purchases. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.

Thesis-invalidation conditions

Fundamental and falsifiable, never price-based. If one is satisfied the thesis is marked dead and the position is retained only by explicit decision.

Impairment case

Named cause: new-logo acquisition failure compounding through a sales-leadership vacuum, while PANW's bundle takes the greenfield. The evidence is management's own, not inferred: two sales leaders departed at the end of FQ3 FY26 (one replaced, one "in the late stages of hiring"); guidance was explicitly made "prudent… during this transition"; the CFO said new logos are where ZS "has not been performing as well as we'd like" and took "a tempered view of new logos going into 2027"; and FY27 growth was guided to 16–17% from 25%. The mechanism of permanent impairment. ZS's economics depend on upse

Documents

ZS Catalyst Calendar ZS Financial Model Notes ZS Research ZS Trade Construction ZS Valuation